how does glp 1 microdosing work GLP-1s: Safety, Dosage, Side Effects, and Results Microdosing of GLP-1's / Wellness
Description
Herein, we successfully switched a patient with acromegaly from a dipeptidyl peptidase-4 (DPP-4) inhibitor to a glucagon-like peptide-1 (GLP-1) analog due to pasireotide-induced deterioration of glycemic control, and we examined the underlying mechanism for glycemic control
95% CI, -1.8 to -0.2 per 1000 person-years
Although lipid profiles, HbA1c, and FBG were unaffected, GLP-1 RA was linked to a slight reduction in SBP (SMD 0.20
Medicines based on glucagon-like peptide-1 (GLP-1) have revolutionized the treatment of diabetes and obesity
